iifl-logo

Somerset Therapeutics Ltd Cash Flow Statement

341.75
(0.35%)
Dec 17, 2020|03:43:23 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Somerset Therapeutics Ltd FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2020Mar-2018Mar-2017Mar-2016

Profit before tax

-3.62

-9.69

-10.85

-17.94

Depreciation

-7.23

-3.54

-3.63

-3.86

Tax paid

0.56

-0.09

1.21

1.2

Working capital

-43.52

-22.64

-8.91

-7.43

Other operating items

Operating

-53.81

-35.97

-22.19

-28.03

Capital expenditure

82.9

3.54

-20.89

3.69

Free cash flow

29.08

-32.43

-43.08

-24.34

Equity raised

-29.37

-8.8

8.19

38.44

Investing

0

0

0

0

Financing

21.76

-0.66

-1.38

9.4

Dividends paid

0

0

0

0

Net in cash

21.46

-41.9

-36.27

23.49

Somerset Therapeutics Ltd : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.